Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs

Many individually randomized group treatment (IRGT) trials randomly assign individuals to study arms but deliver treatments via shared agents, such as therapists, surgeons, or trainers. Post-randomization interactions induce correlations in outcome measures between participants sharing the same agent. Agents can be nested in or crossed with trial arm, and participants may interact with a single agent or with multiple agents. These complications have led to ambiguity in choice of models but there have been no systematic efforts to identify appropriate analytic models for these study designs. To address this gap, we undertook a simulation study to examine the performance of candidate analytic models in the presence of complex clustering arising from multiple membership, single membership, and single agent settings, in both nested and crossed designs and for a continuous outcome. With nested designs, substantial type I error rate inflation was observed when analytic models did not account for multiple membership and when analytic model weights characterizing the association with multiple agents did not match the data generating mechanism. Conversely, analytic models for crossed designs generally maintained nominal type I error rates unless there was notable imbalance in the number of participants that interact with each agent.

Authors

Institutions

Publication Details

Journal
Statistics in Medicine
Published
2024-09-03
DOI
https://doi.org/10.1002/sim.10206
Citations
6
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
4.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs

David M. Murray, Xueqi Wang, Patrick J. Heagerty, Andrea J. Cook et al.
6 citations
Statistics in Medicine
Statistical Methods in Clinical Trials
4.25
article

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs

David M. Murray, Xueqi Wang, Patrick J. Heagerty, Andrea J. Cook, Qilu Yu, Jonathan Moyer, Yunji Zhou, Elizabeth L. Turner, Fan Li, Rui Wang, Sherri Pals
article en
6 citations

Abstract

Many individually randomized group treatment (IRGT) trials randomly assign individuals to study arms but deliver treatments via shared agents, such as therapists, surgeons, or trainers. Post-randomization interactions induce correlations in outcome measures between participants sharing the same agent. Agents can be nested in or crossed with trial arm, and participants may interact with a single agent or with multiple agents. These complications have led to ambiguity in choice of models but there have been no systematic efforts to identify appropriate analytic models for these study designs. To address this gap, we undertook a simulation study to examine the performance of candidate analytic models in the presence of complex clustering arising from multiple membership, single membership, and single agent settings, in both nested and crossed designs and for a continuous outcome. With nested designs, substantial type I error rate inflation was observed when analytic models did not account for multiple membership and when analytic model weights characterizing the association with multiple agents did not match the data generating mechanism. Conversely, analytic models for crossed designs generally maintained nominal type I error rates unless there was notable imbalance in the number of participants that interact with each agent.

Statistics in MedicineVol. 43(25)
Centers for Disease Control and Prevention (US), National Institutes of Health (US), Harvard University (US), Kaiser Permanente Washington Health Research Institute (US), Duke University (US), University of Washington (US), Yale University (US), National Center for Complementary and Integrative Health (US), Office of the Director (US), Harvard Pilgrim Health Care (US), Duke Institute for Health Innovation (US), Office of Disease Prevention (US)
Openalex Percentile: Top 5%
Statistical Methods in Clinical Trials
4.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.